Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
Authors:
Open Access
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (5) , 347-354
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cellsLeukemia, 2003
- Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialBlood, 2002
- Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)Seminars in Liver Disease, 2002
- A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantationBone Marrow Transplantation, 2002
- LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION PATIENTS1Transplantation, 1996
- Hepatic veno-occlusive disease after bone marrow transplantBlood Reviews, 1993
- Use of prostaglandin E1 for prevention of liver veno‐occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantationBritish Journal of Haematology, 1990
- Noncirrhotic Intrahepatic Portal HypertensionSeminars in Liver Disease, 1986
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958